Pulmonary Arterial Hypertension

A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of MK-5475 in Adults with Pulmonary Arterial Hypertension

Schedule an Appointment

Select an appointment date and time from available spots listed below.